RecruitingNCT05254197

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

The Risk of Growth in Patients With Non-malignant Brain Tumor: SeOuL cOhort of Brain Tumor MONitoring (SOLOMON) Study

Sponsor

Seoul National University Hospital

Enrollment

3,000 participants

Start Date

Jan 1, 2001

Study Type

OBSERVATIONAL

Conditions

Meningioma Schwannoma Brain Tumor, Primary Pituitary Adenoma Gliomas Benign

Summary

The registry of this study was subjected to patients who were radiologically diagnosed with a non-malignant brain tumor at Seoul National University Hospital since 2001, and who have had magnetic resonance (MR) re-examination after first MR exam or will be re-examined because it was determined that immediate treatment would not be needed at the first visit to the hospital. In all MRs taken by patients, the date of imaging and the volume of the tumor are measured, and we aim to establish a natural growth history for non-malignant brain tumors.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking patients in Seoul who have been diagnosed with low-grade brain tumors that did not require immediate treatment. Researchers want to understand how these tumors naturally grow and change over time — and what factors predict when they eventually need treatment. Both a retrospective (past data) and prospective (ongoing follow-up) group are included. **You may be eligible if...** - You are 18 or older - You have been diagnosed with a low-grade brain tumor (WHO grade 2 or lower) by MRI - You had no symptoms requiring immediate treatment at your first hospital visit - You have had (or will have) at least two MRI scans at least 3 months apart - You have not previously received radiation therapy to your brain **You may NOT be eligible if...** - You stopped attending follow-up before your second MRI - Your symptoms worsened rapidly and required immediate treatment within 3 months of your first scan - Follow-up scans suggest your condition is something other than a brain tumor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.